2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Gastroparesis Market?

The escalation in spending on healthcare is anticipated to boost the future expansion of the gastroparesis market. The term healthcare expenditure denotes the collective funds devoted to health services, encompassing hospital-related costs, fees for medical professionals, nursing care, dental services, medicines, and public health programs. The surge in healthcare spending can be credited to various elements, such as a rising elderly demographic, advancements in medical technology, an increased prevalence of chronic diseases, and heightened consumer demands for superior healthcare services. The increase in healthcare expenditure is having a positive impact on the gastroparesis market by facilitating more monetary aid for research and development, broadening the range of treatment options, and enabling patients to have better access to specialized medical services. For example, in May 2023, a report from the Office for National Statistics, a government department based in the UK, showed that between 2022 and 2023, the total spending on healthcare in the UK surged by 5.6%, in comparison to a growth rate of 0.9% in 2022. The total healthcare spending in the UK was approximately $317.63 billion (£292 billion) in 2023. Hence, the escalation in healthcare expenditure is stimulating the gastroparesis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

#What Are the Key Projections for the CAGR of the Gastroparesis Market From 2025 to 2034?

In the past few years, the market size for gastroparesis has seen consistent growth. It is expected to expand from a worth of $6.84 billion in 2024, reaching $7.17 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to the growth during the historic period include an aging population, rising incidence of diabetes, enhanced knowledge of gastrointestinal disorders, changes in treatment guidelines, and increased awareness about gastroparesis.

In the following years, the gastroparesis market size is slated to experience robust growth, reaching $8.82 billion by 2029 with a compound annual growth rate (CAGR) of 5.3%. The anticipated growth within the forecasted period is thanks to the emergence of innovative therapeutic options, the increasing trend towards personalized medicine, the integration of digital health solutions, enhancements in healthcare infrastructure, and a growing emphasis on early diagnosis. Key trends within this period encompass progress in gastric electrical stimulation therapy, expanding research in stem cell therapy, the preference for minimally invasive surgical procedures, the growing usage of wearable health monitoring devices, and an emphasis on patient-centric care models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189

What New Market Trends Are Reshaping theGastroparesis Market and Its Opportunities?

Leading corporations in the gastroparesis marketplace are creating cutting-edge devices to boost their market profitability. These treatment appliances for gastroparesis are specialized medical devices designed to administer or lessen the symptoms related to gastroparesis, a medical condition marked by the stomach’s delayed emptying process. For example, Enterra Medical Inc., an American medical device firm, launched the Enterra Therapy for gastroparesis treatment in 2022. The Enterra Therapy system uses an implanted neurostimulator that generates gentle electric pulses, offering potential reprieve from chronic nausea and vomiting symptoms related to gastroparesis. This therapy is specifically meant for individuals aged 18 to 70 years who are experiencing chronic, unmanageable (drug-refractory) nausea and vomiting associated with gastroparesis of diabetic or idiopathic origin.

Who Are the Leading Market Players Fueling Growth in the Gastroparesis Market Trend?

Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

How is the Global Gastroparesis Market Segemented?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Which Geographics are Influencing the Growth of the Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Gastroparesis Maret 2025, By The Business Research Company:

Specialty Trade Contractors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/specialty-trade-contractors-global-market-report

Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: